MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. Mitochondrial complex I impairment in PD is modeled in vitro by the susceptibility of dopaminergic neurons to the complex I inhibitor 1-methyl-4-phenylpyridinium (MPP+). In the pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Choi, Doo Chul, Chae, Yoon-Jee, Kabaria, Savan, Chaudhuri, Amrita Datta, Jain, Mohit Raja, Li, Hong, Mouradian, M. Maral, Junn, Eunsung
Formato: Artigo
Lenguaje:Inglês
Publicado: Society for Neuroscience 2014
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4166159/
https://ncbi.nlm.nih.gov/pubmed/25232110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0985-14.2014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares